Literature DB >> 8446042

Insulin resistance in the conscious spontaneously hypertensive rat: euglycemic hyperinsulinemic clamp study.

S Hulman1, B Falkner, N Freyvogel.   

Abstract

To determine whether spontaneously hypertensive rats (SHR) are insulin resistant when compared with their genetic control, Wistar-Kyoto rats (WKY), insulin-stimulated glucose utilization was studied in both strains with the euglycemic hyperinsulinemic clamp technique. This methodology can determine if insulin resistance is present and whether it is due to ineffective stimulation of peripheral glucose utilization, or to incomplete suppression of (hepatic) endogenous glucose production (EGP) by insulin, or both. Twelve WKY and 15 SHR (all male) had long-term catheters surgically placed. After surgical recovery, fasting metabolic parameters were measured in the conscious, unstressed state. Clamp studies were then performed on nine WKY and eight SHR. EGP was measured before and during euglycemic hyperinsulinemia with the tracer-dilution technique (6-3H-glucose). Indices of fasting metabolism (plasma glucose, insulin, and hepatic EGP) were not different between WKY and SHR. During the clamp studies, the glucose infusion rate (GIR) required to maintain euglycemia was significantly lower in SHR (SHR, 0.055 +/- 0.003 v WKY, 0.106 +/- 0.001 mmol/kg.min-1; P < .001). EGP was completely suppressed during euglycemic hyperinsulinemia in all WKY and in six of eight SHR. We conclude that conscious, nonstressed SHR are insulin resistant when compared with WKY. Attenuated insulin-stimulated peripheral glucose utilization implicates skeletal muscle, and not liver, as the primary site of insulin resistance in SHR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446042     DOI: 10.1016/0026-0495(93)90165-k

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

1.  Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats.

Authors:  S Vasdev; V Gill; S Parai; L Longerich; V Gadag
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

2.  The antihypertensive effect of arginine.

Authors:  Sudesh Vasdev; Vicki Gill
Journal:  Int J Angiol       Date:  2008

3.  The antihypertensive effect of cysteine.

Authors:  Sudesh Vasdev; Pawan Singal; Vicki Gill
Journal:  Int J Angiol       Date:  2009

4.  Role of aldehydes in fructose induced hypertension.

Authors:  S Vasdev; C A Ford; L Longerich; V Gadag; S Wadhawan
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

5.  Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats.

Authors:  Sudesh Vasdev; Vicki Gill; Sushil Parai; Veeresh Gadag
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

6.  A New Hypothesis for Insulin Resistance in Hypertension Due to Receptor Cleavage.

Authors:  Frank A Delano; Hanrui Zhang; Edward E Tran; Cuihua Zhang; Geert W Schmid-Schönbein
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01-01

7.  THE AUTODIGESTION HYPOTHESIS AND RECEPTOR CLEAVAGE IN DIABETES AND HYPERTENSION.

Authors:  F A Delano; A Y Chen; K-I S Wu; E D Tran; S F Rodrigues; G W Schmid-Schönbein
Journal:  Drug Discov Today Dis Models       Date:  2011

8.  2008 Landis Award lecture. Inflammation and the autodigestion hypothesis.

Authors:  Geert W Schmid-Schönbein
Journal:  Microcirculation       Date:  2009-05       Impact factor: 2.628

9.  Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in beta-cells.

Authors:  C Chen; H Hosokawa; L M Bumbalo; J L Leahy
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 10.  Proteolytic receptor cleavage in the pathogenesis of blood rheology and co-morbidities in metabolic syndrome. Early forms of autodigestion.

Authors:  Rafi Mazor; Geert W Schmid-Schönbein
Journal:  Biorheology       Date:  2015       Impact factor: 1.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.